Skip to main content

Advertisement

Log in

Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on 18F-FDG-PET/CT

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to assess the imaging features and natural course of hilar and mediastinal sarcoid-like reaction on 18F-fluorodeoxyglucose (FDG) PET/CT after the treatment of malignancies.

Methods

Sixteen patients with the appearance of sarcoid-like reaction seen on 18F-FDG-PET/CT after treatment were included. Hilar and mediastinal lymph node metastases were pathologically or clinically ruled out. Posttreatment 18F-FDG-PET/CT imaging features were assessed.

Results

The maximum standardized uptake values of sarcoid-like reaction were 3.8–13.6 (mean 6.8). FDG uptake of hilar nodes was symmetrical in 12 (75%) patients and asymmetrical in 4 (25%). The time interval between the initiation of therapy and appearance of sarcoid-like reaction was 9–86 months (median 27.1 months). Among 14 patients who underwent further follow-up using 18F-FDG-PET/CT, sarcoid-like reaction regressed in 11 (79%) patients and did not regress in 3 (21%) patients. The time interval between the appearance of sarcoid-like reaction and its regression was 3–80 months (median, 8.5 months).

Conclusion

After the treatment of malignancies, benign sarcoid-like reaction was rarely observed during follow-up. Although sarcoid-like reaction appeared a long time after the treatment of malignancies, it frequently and spontaneously regressed in a relatively short period of time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sacks EL, Donaldson SS, Gordon J, Dorfman RF. Epithelioid granulomas associated with Hodgkin’s disease: clinical correlations in 55 previously untreated patients. Cancer. 1978;41(2):562–7.

    Article  CAS  PubMed  Google Scholar 

  2. Hunsaker AR, Munden RF, Pugatch RD, Mentzer SJ. Sarcoidlike reaction in patients with malignancy. Radiology. 1996;200(1):255–61.

    Article  CAS  PubMed  Google Scholar 

  3. Gooneratne L, Nagi W, Lim Z, Ho AY, Devereux S, Pagliuca A, et al. Sarcoidosis and haematological malignancies: is there an association? Br J Haematol. 2008;141(2):260–2.

    Article  PubMed  Google Scholar 

  4. Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern. Clin Radiol. 2009;64(7):675–81.

    Article  CAS  PubMed  Google Scholar 

  5. Inoue K, Goto R, Shimomura H, Fukuda H. FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment. Springerplus. 2013;2(1):113.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Blank N, Lorenz HM, Ho AD, Witzens-Harig M. Sarcoidosis and the occurrence of malignant diseases. Rheumatol Int. 2014;34(10):1433–9.

    Article  PubMed  Google Scholar 

  7. London J, Grados A, Ferme C, Charmillon A, Maurier F, Deau B, et al. Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature. Medicine (Baltimore). 2014;93(21):e121.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Grados A, Ebbo M, Bernit E, Veit V, Mazodier K, Jean R, et al. Sarcoidosis occurring after solid cancer: a nonfortuitous association: report of 12 cases and review of the literature. Medicine (Baltimore). 2015;94(28):e928.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lau RK, Takasugi JE, David Godwin J, Pipavath SN. Sarcoid-like reaction-computed tomography features in 12 patients. J Comput Assist Tomogr. 2015;39(2):143–8.

    Article  PubMed  Google Scholar 

  10. Arish N, Kuint R, Sapir E, Levy L, Abutbul A, Fridlender Z, et al. Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence? Respiration. 2017;93(4):247–52.

    Article  CAS  PubMed  Google Scholar 

  11. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer. 1974;29(3):247–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol. 2009;20(6):1121–6.

    Article  CAS  PubMed  Google Scholar 

  13. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1668–72.

    Article  CAS  PubMed  Google Scholar 

  14. Piekarski E, Benali K, Rouzet F. Nuclear imaging in sarcoidosis. Semin Nucl Med. 2018;48(3):246–60.

    Article  PubMed  Google Scholar 

  15. Keijsers RG, van den Heuvel DA, Grutters JC. Imaging the inflammatory activity of sarcoidosis. Eur Respir J. 2013;41(3):743–51.

    Article  CAS  PubMed  Google Scholar 

  16. Mostard RL, van Kroonenburgh MJ, Drent M. The role of the PET scan in the management of sarcoidosis. Curr Opin Pulm Med. 2013;19(5):538–44.

    Article  PubMed  Google Scholar 

  17. Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko V, Saranovic D, et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nucl Med. 2012;53(10):1543–9.

    Article  PubMed  Google Scholar 

  18. Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev. 1986;13(3):147–56.

    Article  CAS  PubMed  Google Scholar 

  19. Umezu H, Chida M, Inoue T, Araki O, Tamura M, Tatewaki M, et al. Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease. Gen Thorac Cardiovasc Surg. 2010;58(8):434–7.

    Article  PubMed  Google Scholar 

  20. Maeda J, Ohta M, Hirabayashi H, Matsuda H. False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer. Jpn J Thorac Cardiovasc Surg. 2005;53(4):196–8.

    Article  PubMed  Google Scholar 

  21. Skipworth RJ, Stewart GD, Dejong CH, Preston T, Fearon KC. Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr. 2007;26(6):667–76.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors declare that there is no funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroki Kato.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

The authors declare that they preserve ethical standards.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaneko, Y., Kato, H. & Matsuo, M. Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on 18F-FDG-PET/CT. Jpn J Radiol 37, 88–94 (2019). https://doi.org/10.1007/s11604-018-0786-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-018-0786-4

Keywords

Navigation